The retained enzymatic activity in vitro and the significant reduction of Aβ monomers and Aβ oligomers in vivo following a single intravenous injection highlight the potential of recombinant NEP-based proteins in AD although a modified construct with better brain retention would be desired. Here, MME is linked to Alzheimer disease.